Pfizer, EMD Serono to scrap phase 3 study of avelumab in LA SCCHN

Pfizer to terminate the JAVELIN Head and Neck 100 study evaluating avelumab in addition to CRT in LA SCCHN (Credit: Coolcaesar/Wikipedia.org)